期刊文献+

血液灌流联合血液透析对血液透析患者甲状旁腺素的清除效果观察 被引量:7

Tpeatment study of hemoperfusion combined with hemodialysis in eliminating parathyroid hormone due to uremia
下载PDF
导出
摘要 目的观察血液灌流联合血液透析对血液透析患者甲状旁腺素的清除效果观察。方法将50例尿毒症合并顽固性皮肤瘙痒患者,随机分为两组。串联组22例,采用血液灌流联合血液透析治疗,每周3次。对照组28例,采用常规血液透析治疗,每周3次,共治疗4周。治疗前、后测定血清甲状旁腺素的水平。结果串联组治疗前血清甲状旁腺素为(325.85±218.65)ng/L,治疗后降至(153.80±248.65)ng/L,皮肤瘙痒症状改善率77.78%,治疗前、后比较差异显著(P〈0.05)。对照组治疗前血清甲状旁腺素为(392.85±248.65)ng/L,治疗后降至(348.79±231.65)ng/L,皮肤瘙痒症状改善率29.41%,治疗前、后比较差异无显著性(P〉0.05)。结论血液灌流联合血液透析能有效地清除血清甲状旁腺素,改善患者的皮肤瘙痒症状。 Objective To study the effect of hemoperfusion combined with hemodialysis in eliminating parathyroid hormone with uremia. Methods Fifty patients with uremia were randomly divided into two groups: series groups (n = 22) were given hemoperfusion combined with hemodialysis three a week. The control groups (n = 28) were treated with hemodialysis exclusively. The total observation period was one month. During the treatment, plsama parathyroid hormone concentration was measured. Results In series groups the parathyroid hormone decreased from (325. 85 ±218. 65) ng/L to (153. 80±248. 65) ng/L, the skin itches alleviating rate was 77. 78%, with a significant difference from pretreatment (P 〈0. 05 ). In hemodialysis groups the parathyroid hormone decreased from (392. 85±248. 65) ng/L to (348. 79 ±231.65) ng/L, the skin itches alleviating rate was 29. 41%, without a significant difference from pretreatment (P〈0.05). Conclusions Hemoperfusion combined with hemodialysis can effectively eliminate parathyroid hormone in patients with uremia, alleviate the skin pruritus.
作者 徐燕 凌凯
出处 《临床肾脏病杂志》 2011年第6期267-269,共3页 Journal Of Clinical Nephrology
关键词 灌流 肾透析 甲状旁腺素 Perfusion Renal Dialysis Parathyroid Hormone
  • 相关文献

参考文献4

二级参考文献10

共引文献28

同被引文献34

  • 1王梅.重视透析患者钙磷代谢紊乱及其骨病的控制[J].中国血液净化,2006,5(7):349-350. 被引量:22
  • 2吴国荃.慢性肾功能不全及替代治疗[M].北京:人民卫生出版社,1997:130.
  • 3黎磊石,刘志红.中国肾脏病学[M].北京:人民军医出版社.2011:1628.
  • 4Shinazato T,Maeda K.Push/Pull hemodiafiltration[J].Contrib Nephro,2007,15$(1) : 169.
  • 5Goodman WG. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis [ J ]. Semin Dial,2007,20 ( 1 ) : 1-4.
  • 6Souberbielle JC, Cavalier E, Jean G. Interpretation of serum parathy- roid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory [ J ].? ClinChem Lab Med,2010,48 (6) :769-774.
  • 7孙岩,赵青平.血液透析联合血液灌流治疗尿毒症的临床研究[J].临床与实践,2012,10(12):37.
  • 8Floege J,Ketteler M.β2-microglobulin-derived a myloidosis:an update[J].Kidney Int,2001,78(suppl):s164-s171.
  • 9Vanholder R,Glorieux G,Desmet R,et al.New insights in uremic to xins[J].Kidney Int(suppl),2003(32):6-10.
  • 10樊晓红,熊重祥,王新华,胡静.血液透析联合血液灌流与联合血液透析滤过对维持性血液透析患者皮肤瘙痒的疗效观察[J].中国血液净化,2009,8(3):137-141. 被引量:48

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部